전남대학교 중앙도서관

MOLECULAR AND PHENOTYPIC CHARACTERISATION OF INTRA-TUMOURAL HETEROGENEITY IN HIGH GRADE SEROUS OVARIAN CANCER: EP1226

학술저널

issue: International Journal of Gynecological Cancer. Nov 01, 2019 29 ESGO Annual Meeting Abstracts:A50-A51
Author: Cunnea, P
Curry, E
Nixon, K
Thol, K
Wulandari, R
Bowtell, D
McNeish, I
Fotopoulou, C
DB Label: Database : Journals@OVID

원문보기: 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE) 등재 - SCOPUS

CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction.

학술저널

issue: Nature protocols [Nat Protoc] 2024 Jan; Vol. 19 (1), pp. 159-183. Date of Electronic Publication: 2023 Nov 28.
Author: Grigoriadis K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Bunkum A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Lab, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK.
Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Thol K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.
Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.
Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. s.zaccaria@ucl.ac.uk.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK. s.zaccaria@ucl.ac.uk.
McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (Nature) 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE)

Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes.

학술저널

issue: Cell reports. Medicine [Cell Rep Med] 2023 Jun 20; Vol. 4 (6), pp. 101055. Date of Electronic Publication: 2023 May 22.
Author: Cunnea P; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK. Electronic address: p.cunnea@imperial.ac.uk.
Curry EW; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
Christie EL; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3010, Australia.
Nixon K; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
Kwok CH; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
Pandey A; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Wulandari R; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
Thol K; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
Ploski J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
Morera-Albert C; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
McQuaid S; Queen's University Belfast, Belfast BT7 1NN, UK.
Lozano-Kuehne J; Experimental Cancer Medicine Centre, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
Clark JJ; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
Krell J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
Stronach EA; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
McNeish IA; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
Bowtell DDL; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3010, Australia.
Fotopoulou C; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK; West London Gynaecological Cancer Centre, Imperial College NHS Trust, London W12 0HS, UK. Electronic address: c.fotopoulou@imperial.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (Clinical Key) Open Access (PubMed Central) Full Text (ScienceDirect O/A) 등재 - Web of Science (SCIE) 등재 - SCOPUS

Genomic-transcriptomic evolution in lung cancer and metastasis.

학술저널

issue: Nature [Nature] 2023 Apr; Vol. 616 (7957), pp. 543-552. Date of Electronic Publication: 2023 Apr 12.
Author: Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Puttick C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Demeulemeester J; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Integrative Cancer Genomics Laboratory, Department of Oncology, KU Leuven, Leuven, Belgium.; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Larose Cadieux E; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Medical Genomics, University College London Cancer Institute, London, UK.
Thol K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Jones TP; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Ward S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
Cubitt L; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
Athanasopoulou F; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK.
Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Castignani C; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Medical Genomics, University College London Cancer Institute, London, UK.
Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Al Bakir M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Tanić M; Medical Genomics, University College London Cancer Institute, London, UK.; Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Lim EL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Al-Rashed AM; Centre for Nephrology, Division of Medicine, University College London, London, UK.
Lang D; Scientific Computing STP, Francis Crick Institute, London, UK.
Clements J; Scientific Computing STP, Francis Crick Institute, London, UK.
Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.
de Carné Trécesson S; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.
East P; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.
Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK.
Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.
Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, London, UK.
Beck S; Medical Genomics, University College London Cancer Institute, London, UK.
Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.
Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute and University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.; Department of Medical Oncology, University College London Hospitals, London, UK. Charles.Swanton@crick.ac.uk.
McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (Nature) 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE) 등재 - SCOPUS

The evolution of lung cancer and impact of subclonal selection in TRACERx.

학술저널

issue: Nature [Nature] 2023 Apr; Vol. 616 (7957), pp. 525-533. Date of Electronic Publication: 2023 Apr 12.
Author: Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Dietzen M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
Ward S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Huebner A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Bunkum A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK.
Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Grigoriadis K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK.
Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Liu WK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
Thol K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Bailey C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Bentham R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Le Quesne J; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Pathology Department, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.
Biswas D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Puttick C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK.
Lee C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Division of Medicine, University College London, London, UK.
Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Smith J; Scientific Computing, The Francis Crick Institute, London, UK.
Xing W; Scientific Computing, The Francis Crick Institute, London, UK.
Nicod J; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
Price G; Department of Medical Oncology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK.; University of Aberdeen, Aberdeen, UK.
Kerr KM; University of Aberdeen, Aberdeen, UK.; Department of Pathology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK.
Naidu B; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.
Middleton G; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Blyth KG; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Queen Elizabeth University Hospital, Glasgow, UK.
Fennell DA; University of Leicester, Leicester, UK.; University Hospitals of Leicester NHS Trust, Leicester, UK.
Forster MD; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK.
Lee SM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK.
Falzon M; Department of Cellular Pathology, University College London Hospitals, London, UK.
Hewish M; Royal Surrey Hospital, Royal Surrey Hospitals NHS Foundation Trust, Guilford, UK.; University of Surrey, Guilford, UK.
Shackcloth MJ; Liverpool Heart and Chest Hospital, Liverpool, UK.
Lim E; Academic Division of Thoracic Surgery, Imperial College London, London, UK.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Benafif S; Department of Oncology, University College London Hospitals, London, UK.
Russell P; Princess Alexandra Hospital, The Princess Alexandra Hospital NHS Trust, Harlow, UK.
Boleti E; Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.
Krebs MG; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.
Lester JF; Singleton Hospital, Swansea Bay University Health Board, Swansea, UK.
Papadatos-Pastos D; Department of Oncology, University College London Hospitals, London, UK.
Ahmad T; Department of Oncology, University College London Hospitals, London, UK.
Thakrar RM; Department of Thoracic Medicine, University College London Hospitals, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Lawrence D; Department of Thoracic Surgery, University College London Hospital NHS Trust, London, UK.
Navani N; Department of Thoracic Medicine, University College London Hospitals, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK.
Blackhall FH; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.
Summers Y; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.
Cave J; Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Marafioti T; Department of Cellular Pathology, University College London Hospitals, London, UK.
Herrero J; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Peggs KS; Department of Haematology, University College London Hospitals, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Schwarz RF; Institute for Computational Cancer Biology, Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Berlin Institute for the Foundations of Learning and Data (BIFOLD), Berlin, Germany.
Van Loo P; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.
Miedema DM; LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands.
Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.
Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, London, UK.
Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK.
Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk.
McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.
Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (Nature) 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE) 등재 - SCOPUS

Therapy sculpts the complex interplay between cancer and the immune system during tumour evolution.

학술저널

issue: Genome medicine [Genome Med] 2022 Dec 07; Vol. 14 (1), pp. 137. Date of Electronic Publication: 2022 Dec 07.
Author: Thol K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.
Pawlik P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.
McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (원문보기) Full Text (원문보기) Open Access (PubMed Central) OA (Springer) Open Access (BioMed Central) 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE) 등재 - SCOPUS

MYO10-filopodia support basement membranes at pre-invasive tumor boundaries.

학술저널

issue: Developmental cell [Dev Cell] 2022 Oct 24; Vol. 57 (20), pp. 2350-2364.e7.
Author: Peuhu E; Institute of Biomedicine and FICAN West Cancer Centre Laboratory, University of Turku, 20520 Turku, Finland; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland. Electronic address: emilia.peuhu@utu.fi.
Jacquemet G; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland; Åbo Akademi University, Faculty of Science and Engineering, Biosciences, 20520 Turku, Finland; Turku Bioimaging, University of Turku and Åbo Akademi University, 20520 Turku, Finland; InFLAMES Research Flagship Center, Åbo Akademi University, 20520 Turku, Finland. Electronic address: guillaume.jacquemet@abo.fi.
Scheele CLGJ; Division of Molecular Pathology, Oncode Institute-Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands; VIB-KU Leuven Center for Cancer Biology, Department of Oncology, 3000 Leuven, Belgium.
Isomursu A; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
Laisne MC; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland; Åbo Akademi University, Faculty of Science and Engineering, Biosciences, 20520 Turku, Finland.
Koskinen LM; Institute of Biomedicine and FICAN West Cancer Centre Laboratory, University of Turku, 20520 Turku, Finland; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
Paatero I; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
Thol K; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
Georgiadou M; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
Guzmán C; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
Koskinen S; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
Laiho A; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
Elo LL; Institute of Biomedicine and FICAN West Cancer Centre Laboratory, University of Turku, 20520 Turku, Finland; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland; InFLAMES Research Flagship Center, University of Turku, 20520 Turku, Finland.
Boström P; Department of Pathology, Turku University Hospital, 20520 Turku, Finland; University of Turku, 20520 Turku, Finland.
Hartiala P; University of Turku, 20520 Turku, Finland; Department of Plastic and General Surgery, Turku University Hospital, 20520 Turku, Finland.
van Rheenen J; Division of Molecular Pathology, Oncode Institute-Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands.
Ivaska J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland; InFLAMES Research Flagship Center, University of Turku, 20520 Turku, Finland; Department of Life Technologies, University of Turku, 20520 Turku, Finland; Western Finnish Cancer Center (FICAN West), University of Turku, FI-20520 Turku, Finland; Foundation for the Finnish Cancer Institute, Tukholmankatu 8, FI-00014 Helsinki, Finland. Electronic address: johanna.ivaska@utu.fi.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect O/A) 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE)

Potential Use of Shared Frameshift Mutations in 'Off-the-Shelf' Neoantigen Vaccines.

학술저널

issue: Trends in cancer [Trends Cancer] 2021 Mar; Vol. 7 (3), pp. 175-177. Date of Electronic Publication: 2021 Jan 23.
Author: Thol K; Cancer Genome Evolution Research Group, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.
McGranahan N; Cancer Genome Evolution Research Group, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. Electronic address: nicholas.mcgranahan.10@ucl.ac.uk.
DB Label: Database : MEDLINE

원문보기: 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE) 등재 - SCOPUS

Preperitoneal Fat Grafting Inhibits the Formation of Intra-abdominal Adhesions in Mice.

학술저널

issue: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract [J Gastrointest Surg] 2020 Dec; Vol. 24 (12), pp. 2838-2848. Date of Electronic Publication: 2019 Dec 10.
Author: Laukka M; Department of Plastic and General Surgery, Turku University Hospital, Turku, Finland.; Institute of Biomedicine, University of Turku, Turku, Finland.
Hoppela E; Department of Plastic and General Surgery, Turku University Hospital, Turku, Finland.
Salo J; Institute of Biomedicine, University of Turku, Turku, Finland.
Rantakari P; Institute of Biomedicine, University of Turku, Turku, Finland.
Gronroos TJ; Turku PET Centre, University of Turku, Turku, Finland.; Medicity Research Laboratories, University of Turku, Turku, Finland.
Orte K; Genetics and Saske Tyks Laboratory Division, Turku University Hospital, Turku, Finland.
Auvinen K; Institute of Biomedicine, University of Turku, Turku, Finland.; Medicity Research Laboratories, University of Turku, Turku, Finland.
Salmi M; Institute of Biomedicine, University of Turku, Turku, Finland.; Medicity Research Laboratories, University of Turku, Turku, Finland.
Gerke H; Institute of Biomedicine, University of Turku, Turku, Finland.
Thol K; Centre for Biotechnology, University of Turku, Turku, Finland.
Peuhu E; Centre for Biotechnology, University of Turku, Turku, Finland.; FICAN West Cancer Laboratory, Turku University Hospital and University of Turku, Turku, Finland.
Kauhanen S; Department of Gastrointestinal Surgery, Turku University Hospital, Turku, Finland.
Merilahti P; Institute of Biomedicine, University of Turku, Turku, Finland.
Hartiala P; Department of Plastic and General Surgery, Turku University Hospital, Turku, Finland. pauliina.hartiala@tyks.fi.; Institute of Biomedicine, University of Turku, Turku, Finland. pauliina.hartiala@tyks.fi.
DB Label: Database : MEDLINE

원문보기: 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE)

링크메뉴

주메뉴

전자자료 상세검색

전자자료 상세검색

전체선택